A South Korean court has hit pause on the penalties imposed by the country’s accounting regulator against Samsung BioLogics for the way it handled a joint venture with Biogen. More: Court cuts Samsung BioLogics a break during probe of its
read moreAbcam has announced a research collaboration with the Loulou Foundation to discover new tools to advance research for the development of therapeutics for CDKL5 Deficiency Disorder. More: Abcam and Loulou Foundation form CDKL5 deficiency disorder partnership Source: News
read moreNHS England’s medical director has welcomed the introduction of stronger mental health safeguards for Superdrug’s new high street botox plan. More: Superdrug to offer stricter mental health checks for Botox users Source: News
read moreThe European Commission has expanded the use of Orkambi to include children with cystic fibrosis aged two years to five years. More: Orkambi's use expanded for younger children Source: News
read moreThe UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given formal approval for Redx Pharma to re-commence a Phase I/IIa trial of experimental cancer therapy RXC004. More: MHRA grants approval for RXC004 trial restart Source: News
read moreScientists have uncovered 52 new genetic changes linked to osteoarthritis, doubling the number of genetic regions found to be associated with the disabling condition, potentially paving the way for the development of disease-modifying therapies. More: Genetic study reveals possible new osteoarthritis
read more© 1994 - 2026 B.M. Pharmaceuticals